STAT Plus: This is awkward: Genome editing startup Beam has competition — from one of its own cofounders
Beam and its bankers are likely to face questions from investors about whether David Liu’s new endeavor creates scientific and financial conflicts.
No hay comentarios:
Publicar un comentario